| 摘要 |
The use of a compound with structural formula (I) or the N-oxide thereof, wherein R1 is H or lower alkyl and R2 is C1-20 alkyl or C2-20 alkenyl with one or two unsaturated bonds, or a pharmaceutically acceptable salt, ester or salt of such ester or amide of such compounds, in the manufacture of a medicament for treating infection by microaerophilic bacteria, especially Helicobacter pylori. 2-heptyl-4-hydroxyquinoline, 2-nonyl-4-hydroxyquinoline, 2-nonenyl-4-hydroxyquinoline and their N-oxides are preferred. |
